Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.33 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | METAP1 | P53582 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.32 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.32 |
| ▸ | CPN1 | P15169 | 1/20 | 0.31 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4978274 | 0.79 | CA2 (0.47) | CA2MAPK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL27985308 | 0.78 | CA1 (0.31) | CA2 | |
| SCHEMBL5696321 | 0.78 | LCK (0.44) | SLC1A2SLC1A1GPR84FFAR1MAPT | |
| SCHEMBL407615 | 0.76 | CA2 (0.44) | CA2MAPK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL1527354 | 0.76 | CA2 (0.44) | CA2MAPK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL28220778 | 0.76 | CA2 (0.38) | CA2MAPK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL27981769 | 0.76 | CA2 (0.40) | CA2MAPK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL435610 | 0.75 | CYP2C9 (0.45) | CA2MAPK1METAP1LCKPPARD | |
| SCHEMBL1571118 | 0.74 | GRIK1 (0.34) | — | |
| SCHEMBL9722690 | 0.73 | CA2 (0.41) | CA2MAPK1SLC1A3SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104059048-B | A kind of preparation method of the chiral intermediate for statins | 凯莱英医药集团（天津）股份有限公司 | 2016-06-08 | — | — | CN | disclosed |